Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination

The results of the Shingles Prevention Study, a Cooperative Studies Program conducted through the US Department of Veterans Affairs, are summarized. Also provided are general recommendations and contraindications for the use of zoster vaccine live among patients aged 60 years or older.

Saved in:
Bibliographic Details
Published inThe Journal of the American Osteopathic Association Vol. 109; no. 6 Suppl 2; pp. S18 - S21
Main Author Gelb, Lawrence D
Format Journal Article
LanguageEnglish
Published United States 01.06.2009
Subjects
Age Factors
Aged
Herpes Zoster - epidemiology
Herpes Zoster - prevention & control
Herpes Zoster Vaccine
Humans
Incidence
Middle Aged
Online AccessGet full text

Cover

More Information
Summary:The results of the Shingles Prevention Study, a Cooperative Studies Program conducted through the US Department of Veterans Affairs, are summarized. Also provided are general recommendations and contraindications for the use of zoster vaccine live among patients aged 60 years or older.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1945-1997